Journal of Thrombosis and Thrombolysis View Homepage


Ontology type: schema:Periodical     


Journal Info

START YEAR

1966

PUBLISHER

Springer US

LANGUAGE

en

HOMEPAGE

https://link.springer.com/journal/11239

Recent publications latest 20 shown

  • 2022-11-25 Hyperdense middle cerebral artery sign predicts favorable outcome in patients undergoing mechanical thrombectomy
  • 2022-11-19 Trends in utilization, reimbursement, and price for DOACs and warfarin in the US Medicaid population from 2000 to 2020
  • 2022-11-19 Incidence and outcomes of splanchnic vein thrombosis after diagnosis of COVID-19 or COVID-19 vaccination: a systematic review and meta-analysis
  • 2022-11-17 Empagliflozin activates JAK2/STAT3 signaling and protects cardiomyocytes from hypoxia/reoxygenation injury under high glucose conditions
  • 2022-11-15 l-carnitine modulates free mitochondrial DNA DAMPs and platelet storage lesions during storage of platelet concentrates
  • 2022-11-13 Targeted genetic analysis unveils novel associations between ACE I/D and APO T158C polymorphisms with D-dimer levels in severe COVID-19 patients with pulmonary embolism
  • 2022-11-12 Platelet function testing in atrial fibrillation patients undergoing percutaneous coronary intervention
  • 2022-11-10 Retrospective review of Andexanet Alfa versus 4-Factor Prothrombin Complex Concentrate for reversal of DOAC-Associated Intracranial Hemorrhage
  • 2022-11-09 Use of SAMe-TT2R2 in a racially diverse anticoagulation clinic: prediction of optimal anticoagulation
  • 2022-11-09 Stable CAD patients show higher levels of platelet-borne TGF-β1 associated with a superior pro-inflammatory state than the pro-aggregatory status; Evidence highlighting the importance of platelet-derived TGF-β1 in atherosclerosis
  • 2022-11-09 Impact of clinical profile at admission on the outcomes in patients hospitalized for acute pulmonary embolism: data from the IPER Registry
  • 2022-11-08 Time from blood draw to multiple electrode aggregometry and association with platelet reactivity
  • 2022-11-07 A multicentre observational study of the prevalence, management, and outcomes of subsegmental pulmonary embolism
  • 2022-11-06 Temporal trend in venous thromboembolism hospitalization rates in Brazilian older adults, 2010–2020
  • 2022-11-03 Higher OAK (Oral Anticoagulation Knowledge) score at baseline associated with better TTR (Time in Therapeutic Range) in patients taking warfarin
  • 2022-11-01 TAVR: nemesis of NOACs?
  • 2022-10-31 Platelet storage: Progress so far
  • 2022-10-28 Net clinical benefit of DOACs vs. usual anticoagulation treatment in venous thromboembolism and active cancer: systematic review and meta-analysis
  • 2022-10-27 Delayed neurological improvement after endovascular treatment for acute large vessel occlusion: data from ANGEL-ACT registry
  • 2022-10-18 Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "alternateName": "A Journal for Translation, Application and Therapeutics in Thrombosis and Vascular Science", 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "1.059999942779541", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "0.9739999771118164", 
            "type": "Rating"
          }
        ], 
        "description": "The Journal of Thrombosis and Thrombolysis is a long-awaited resource for contemporary cardiologists, hematologists, vascular medicine specialists and clinician-scientists actively involved in treatment decisions and clinical investigation of thrombotic disorders involving the cardiovascular and cerebrovascular systems. The principal focus of the Journal centers on the pathobiology of thrombosis and vascular disorders and the use of anticoagulants, platelet antagonists, cell-based therapies and interventions in scientific investigation, clinical-translational research, population science and patient care. In keeping with our commitment to contemporary topics and scientific advance on a global scale, the Journal has established a section dedicated to the COVID-19 pandemic with an accelerated peer review, decision, and publication of scholarly review papers, observational studies and randomized clinical trials that will inform scientific undertakings and patient management.
    \n
    \nThe Journal will publish original work which emphasizes the interface between fundamental scientific principles and clinical investigation, stimulating an interdisciplinary and scholarly dialogue in thrombosis and vascular medicine. Published works will also define platforms for translational research, drug development, clinical trials, new drugs and devices, and patient-directed applications. The Journal of Thrombosis and Thrombolysis' integrated format will expand the reader's knowledge base and provide important insights for both the investigation and direct clinical application of the most rapidly growing fields in medicine-thrombosis and vascular medicine.
    \n
    \nThe Journal seeks original manuscripts devoted to fundamental science in cardiovascular disease, laboratory investigation, pharmacogenetics, clinical research, global health, population science, and epidemiology. State-of-the-art reviews, position papers and editorials will be summoned by invitation from the editor or an appointed guest editor. The Journal will publish special issues and supplements from national and international symposia and scientific committees in a timely fashion by working closely with organizers and contributing authors.
    \n
    \nManuscripts submitted must not be under consideration by another journal and should not have been published elsewhere in similar form. All articles will be reviewed by a minimum of two highly qualified referees. All clinical trials being considered for publication will also be reviewed by a statistician. A response will be provided within 2-3 weeks of receipt.
    \n ", "editor": [ { "familyName": "Becker", "givenName": "Richard", "type": "Person" } ], "id": "sg:journal.1113719", "inLanguage": [ "en" ], "isAccessibleForFree": false, "issn": [ "0929-5305", "1573-742X" ], "license": "Hybrid", "name": "Journal of Thrombosis and Thrombolysis", "productId": [ { "name": "dimensions_id", "type": "PropertyValue", "value": [ "113719" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "sn 95038450" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "9502018" ] }, { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "444020" ] }, { "name": "era_ids_id", "type": "PropertyValue", "value": [ "16532" ] } ], "publisher": { "name": "Springer US", "type": "Organization" }, "publisherImprint": "Springer", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1113719" ], "sdDataset": "journals", "sdDatePublished": "2022-12-01T06:58", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/journal/journal_0.jsonl", "startYear": "1966", "type": "Periodical", "url": "https://link.springer.com/journal/11239" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1113719'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1113719'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1113719'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1113719'


     

    This table displays all metadata directly associated to this object as RDF triples.

    61 TRIPLES      21 PREDICATES      28 URIs      24 LITERALS      10 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1113719 schema:alternateName A Journal for Translation, Application and Therapeutics in Thrombosis and Vascular Science
    2 schema:contentRating N907af8d80bee4d5790bee22f861aa744
    3 Nd74478ee4e5b42c19fbbbcf84c1f5938
    4 schema:description The&nbsp;<em>Journal of Thrombosis and Thrombolysis</em>&nbsp;is a long-awaited resource for contemporary cardiologists, hematologists, vascular medicine specialists and clinician-scientists actively involved in treatment decisions and clinical investigation of thrombotic disorders involving the cardiovascular and cerebrovascular systems. The principal focus of the&nbsp;<em>Journal</em>&nbsp;centers on the pathobiology of thrombosis and vascular disorders and the use of anticoagulants, platelet antagonists, cell-based therapies and interventions in scientific investigation, clinical-translational research, population science and patient care. In keeping with our commitment to contemporary topics and scientific advance on a global scale, the&nbsp;<em>Journal</em>&nbsp;has established a section dedicated to the COVID-19 pandemic with an accelerated peer review, decision, and publication of scholarly review papers, observational studies and randomized clinical trials that will inform scientific undertakings and patient management.<br /> <br /> The&nbsp;<em>Journal</em>&nbsp;will publish original work which emphasizes the interface between fundamental scientific principles and clinical investigation, stimulating an interdisciplinary and scholarly dialogue in thrombosis and vascular medicine. Published works will also define platforms for translational research, drug development, clinical trials, new drugs and devices, and patient-directed applications. The&nbsp;<em>Journal of Thrombosis</em>&nbsp;<em>and Thrombolysis</em>&#39; integrated format will expand the reader&#39;s knowledge base and provide important insights for both the investigation and direct clinical application of the most rapidly growing fields in medicine-thrombosis and vascular medicine.<br /> <br /> The&nbsp;<em>Journal</em>&nbsp;seeks original manuscripts devoted to fundamental science in cardiovascular disease, laboratory investigation, pharmacogenetics, clinical research, global health, population science, and epidemiology. State-of-the-art reviews, position papers and editorials will be summoned by invitation from the editor or an appointed guest editor. The<em>&nbsp;Journal</em>&nbsp;will publish special issues and supplements from national and international symposia and scientific committees in a timely fashion by working closely with organizers and contributing authors.<br /> <br /> Manuscripts submitted must not be under consideration by another journal and should not have been published elsewhere in similar form. All articles will be reviewed by a minimum of two highly qualified referees. All clinical trials being considered for publication will also be reviewed by a statistician. A response will be provided within 2-3 weeks of receipt.<br /> &nbsp;
    5 schema:editor N9497c5fcff0747d3a282b8d06935b10c
    6 schema:inLanguage en
    7 schema:isAccessibleForFree false
    8 schema:issn 0929-5305
    9 1573-742X
    10 schema:license Hybrid
    11 schema:name Journal of Thrombosis and Thrombolysis
    12 schema:productId N169379dac4694b769d83f8d7fff688bb
    13 N1e9596051b594222ac7e8ebcdbb8af9d
    14 N6391524cd0774f5ea7b73379896b5722
    15 N71da8cf8cfb04f59b0b891d946f36644
    16 N7e070472c691462696eecae0f8340712
    17 schema:publisher N8d309347ab334c66838dbb5595630b1b
    18 schema:publisherImprint Springer
    19 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1113719
    20 schema:sdDatePublished 2022-12-01T06:58
    21 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    22 schema:sdPublisher N661533876b2846d486a4ec1e81eb3f32
    23 schema:startYear 1966
    24 schema:url https://link.springer.com/journal/11239
    25 sgo:license sg:explorer/license/
    26 sgo:sdDataset journals
    27 rdf:type schema:Periodical
    28 N169379dac4694b769d83f8d7fff688bb schema:name lccn_id
    29 schema:value sn 95038450
    30 rdf:type schema:PropertyValue
    31 N1e9596051b594222ac7e8ebcdbb8af9d schema:name era_ids_id
    32 schema:value 16532
    33 rdf:type schema:PropertyValue
    34 N3e0a2c0cbbca43d89c7690341b455420 rdf:first sjr
    35 rdf:rest rdf:nil
    36 N622cec94bea8483d8b7fdf3d8279d089 schema:familyName Becker
    37 schema:givenName Richard
    38 rdf:type schema:Person
    39 N6391524cd0774f5ea7b73379896b5722 schema:name nlm_unique_id
    40 schema:value 9502018
    41 rdf:type schema:PropertyValue
    42 N661533876b2846d486a4ec1e81eb3f32 schema:name Springer Nature - SN SciGraph project
    43 rdf:type schema:Organization
    44 N71da8cf8cfb04f59b0b891d946f36644 schema:name nsd_ids_id
    45 schema:value 444020
    46 rdf:type schema:PropertyValue
    47 N7a8d14dd463f4b35af8b8a4ceeea1b32 rdf:first snip
    48 rdf:rest rdf:nil
    49 N7e070472c691462696eecae0f8340712 schema:name dimensions_id
    50 schema:value 113719
    51 rdf:type schema:PropertyValue
    52 N8d309347ab334c66838dbb5595630b1b schema:name Springer US
    53 rdf:type schema:Organization
    54 N907af8d80bee4d5790bee22f861aa744 schema:author N3e0a2c0cbbca43d89c7690341b455420
    55 schema:ratingValue 0.9739999771118164
    56 rdf:type schema:Rating
    57 N9497c5fcff0747d3a282b8d06935b10c rdf:first N622cec94bea8483d8b7fdf3d8279d089
    58 rdf:rest rdf:nil
    59 Nd74478ee4e5b42c19fbbbcf84c1f5938 schema:author N7a8d14dd463f4b35af8b8a4ceeea1b32
    60 schema:ratingValue 1.059999942779541
    61 rdf:type schema:Rating
     




    Preview window. Press ESC to close (or click here)


    ...